Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8780939
Reference Type
Journal Article
Title
A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effects
Author(s)
Zhou, Y; Cong, X; Zhang, H; Peng, C
Year
2020
Is Peer Reviewed?
Yes
Journal
Biomedicine & Pharmacotherapy
ISSN:
0753-3322
EISSN:
1950-6007
Publisher
Elsevier
Volume
130
Issue
Elsevier
Page Numbers
110505
Language
English
PMID
32682112
DOI
10.1016/j.biopha.2020.110505
Web of Science Id
WOS:000582697900016
URL
https://linkinghub.elsevier.com/retrieve/pii/S0753332220306983
Exit
Abstract
Increasing pharmacological evidence supports that paeoniflorin, a water-soluble monoterpene glycoside isolated from Paeonia lactiflora Pall. (Shaoyao in Chinese), has a wide range of medicinal properties including anti-inflammatory, antioxidant, antithrombotic, anticonvulsive, analgesic, cardioprotective, neuroprotective, hepatoprotective, antidepressant-like, antitumoral, and immune-regulatory activities; as well as enhancing cognition and attenuating learning impairment. In addition to pharmacodynamic studies, information on pharmacokinetics is also significant for the further development and utilization of paeoniflorin. The present review focuses on the absorption, distribution, metabolism, and excretion of paeoniflorin, especially main pharmacological activities of paeoniflorin on inflammation and immune function. According to the findings obtained both in vitro and in vivo, a broad application prospect has been opened for paeoniflorin. However, further studies are needed to clarity the direct molecular mechanisms and key targets underlying the beneficial effects of paeoniflorin on inflammation and immunity.
Keywords
Paeoniflorin; Metabolism; Pharmacokinetics; Inflammation; Immunity; ALLERGIC CONTACT-DERMATITIS; HUMAN HEPATOCELLULAR-CARCINOMA; IMIQUIMOD-INDUCED PSORIASIS; BLOOD MONONUCLEAR-CELLS; FIBROBLAST-LIKE SYNOVIOCYTES; INDUCED OXIDATIVE STRESS; PAEONIA-LACTIFLORA; IMPROVES SURVIVAL; INHIBITS FUNCTION; DENDRITIC CELLS
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity